Tranexamic Acid in Orthopaedic Trauma Surgery



Status:Active, not recruiting
Conditions:Hospital, Orthopedic
Therapuetic Areas:Orthopedics / Podiatry, Other
Healthy:No
Age Range:18 - Any
Updated:7/13/2018
Start Date:May 2012
End Date:December 2018

Use our guide to learn which trials are right for you!

Tranexamic acid is an antifibrinolytic drug that has been used to decrease post-operative
blood loss. This study is a prospective, randomized controlled trial investigating the use of
tranexamic acid in fracture surgery around the hip and knee, in which significant blood loss
(>300mL) is expected.

The hypothesis of this study is that tranexamic acid will be associated with a decrease in
post-operative blood loss, as well as a decreased need for allogenic blood transfusion, in
patients who have fracture surgery around the hip and knee.


Inclusion Criteria:

- Patients with isolated fractures of the pelvic ring, acetabulum, femur or tibia that
will require open reduction and internal fixation

- Expected blood loss is greater than 300 mL

- Age ≥ 18

- Skeletal maturity

Exclusion Criteria:

- Pregnant or breastfeeding

- Patients taking oral contraceptives

- Contraindication to venous thromboembolic event (VTE) prophylaxis (intracranial,
intrathoracic, intra-abdominal bleeding or spine fractures)

- Patients requiring operative intervention for other injuries (orthopaedic or
non-orthopaedic)

- Known hypercoagulable state including history of prescribed anti-coagulation
(warfarin, plavix, low molecular weight heparin)

- Renal Insufficiency (creatinine greater than 1.5mg/dL)

- Open fractures
We found this trial at
1
site
Chattanooga, Tennessee 37403
?
mi
from
Chattanooga, TN
Click here to add this to my saved trials